Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-06 Sale |
2023-01-10 7:19 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer |
2,403 | $36.3 | $87,225 | 214,355 (Direct) |
View |
| 2022-01-06 Purchase |
2022-01-10 8:30 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer |
6,842 | $19 | $129,998 | 344,258 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-12-27 Exercise |
2023-12-29 4:07 pm |
N/A 2029-05-13 |
Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer |
25,000 | $0 | 320,685 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 4:07 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer |
25,000 | $0.37 | 320,685 (Direct) |
View |
| 2023-07-12 Exercise |
2023-07-14 4:20 pm |
N/A 2029-05-13 |
Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer |
20,000 | $0 | 320,685 (Direct) |
View |
| 2023-07-12 Exercise |
2023-07-14 4:20 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer |
20,000 | $0.37 | 320,685 (Direct) |
View |
| 2023-05-22 Gift |
2023-05-24 4:38 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer |
1,580 | $0 | 231,108 (Direct) |
View |
| 2023-03-16 Option Award |
2023-03-20 8:27 pm |
N/A 2033-03-16 |
Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer |
100,833 | $0 | 315,188 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 8:30 pm |
N/A 2032-01-06 |
Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer |
155,833 | $0 | 344,258 (Direct) |
View |
Ownership |
2022-01-06 5:07 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer |
0 | $0 | 336,160 (Direct) |
View |